BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29417354)

  • 21. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.
    Corces-Zimmerman MR; Hong WJ; Weissman IL; Medeiros BC; Majeti R
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2548-53. PubMed ID: 24550281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group.
    Aynardi J; Manur R; Hess PR; Chekol S; Morrissette JJD; Babushok D; Hexner E; Rogers HJ; Hsi ED; Margolskee E; Orazi A; Hasserjian R; Bagg A
    Br J Haematol; 2018 Jul; 182(1):78-85. PubMed ID: 29767839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.
    Pasca S; Chifotides HT; Verstovsek S; Bose P
    Int Rev Cell Mol Biol; 2022; 366():83-124. PubMed ID: 35153007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous leukemic clones identified by NPM1 mutation analysis in patient with acute monocytic leukemia.
    Qiao C; Zhang R; Hong M; Wang L; Zhang JF; Wu YJ; Qiu HR; Qiu HX; Qian SX; Lu H; Zhang SJ; Li JY
    Leuk Lymphoma; 2012 May; 53(5):886-90. PubMed ID: 22035378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia.
    Hartmann L; Nadarajah N; Meggendorfer M; Höllein A; Vetro C; Kern W; Haferlach T; Haferlach C; Stengel A
    Leukemia; 2020 Mar; 34(3):811-820. PubMed ID: 31719678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What are the molecular mechanisms driving the switch from MPNs to leukemia?
    Wang X; Hoffman R
    Best Pract Res Clin Haematol; 2021 Mar; 34(1):101254. PubMed ID: 33762108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
    Rothenberg-Thurley M; Amler S; Goerlich D; Köhnke T; Konstandin NP; Schneider S; Sauerland MC; Herold T; Hubmann M; Ksienzyk B; Zellmeier E; Bohlander SK; Subklewe M; Faldum A; Hiddemann W; Braess J; Spiekermann K; Metzeler KH
    Leukemia; 2017 Dec; ():. PubMed ID: 29249818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of clonal evolution in myelodysplastic syndromes.
    Makishima H; Yoshizato T; Yoshida K; Sekeres MA; Radivoyevitch T; Suzuki H; Przychodzen B; Nagata Y; Meggendorfer M; Sanada M; Okuno Y; Hirsch C; Kuzmanovic T; Sato Y; Sato-Otsubo A; LaFramboise T; Hosono N; Shiraishi Y; Chiba K; Haferlach C; Kern W; Tanaka H; Shiozawa Y; Gómez-Seguí I; Husseinzadeh HD; Thota S; Guinta KM; Dienes B; Nakamaki T; Miyawaki S; Saunthararajah Y; Chiba S; Miyano S; Shih LY; Haferlach T; Ogawa S; Maciejewski JP
    Nat Genet; 2017 Feb; 49(2):204-212. PubMed ID: 27992414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
    Ding L; Ley TJ; Larson DE; Miller CA; Koboldt DC; Welch JS; Ritchey JK; Young MA; Lamprecht T; McLellan MD; McMichael JF; Wallis JW; Lu C; Shen D; Harris CC; Dooling DJ; Fulton RS; Fulton LL; Chen K; Schmidt H; Kalicki-Veizer J; Magrini VJ; Cook L; McGrath SD; Vickery TL; Wendl MC; Heath S; Watson MA; Link DC; Tomasson MH; Shannon WD; Payton JE; Kulkarni S; Westervelt P; Walter MJ; Graubert TA; Mardis ER; Wilson RK; DiPersio JF
    Nature; 2012 Jan; 481(7382):506-10. PubMed ID: 22237025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MLL-PTD in a 13-year-old patient with blast phase myeloproliferative neoplasm: A case report.
    He Z; Wang B; Chen L; Huang Y; Wang H; Yang M; Xiao X; Lu Y; Chen J; Wu Y
    Medicine (Baltimore); 2018 Nov; 97(46):e13220. PubMed ID: 30431598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The multiface morphology of acute leukemia.
    Mittelman M; Floru S; Djaldetti M
    Haematologia (Budap); 1993; 25(3):205-13. PubMed ID: 8119633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.
    Kandarpa M; Wu YM; Robinson D; Burke PW; Chinnaiyan AM; Talpaz M
    Am J Hematol; 2017 Jun; 92(6):555-561. PubMed ID: 28335073
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Smeets MF; Tan SY; Xu JJ; Anande G; Unnikrishnan A; Chalk AM; Taylor SR; Pimanda JE; Wall M; Purton LE; Walkley CR
    Blood; 2018 Aug; 132(6):608-621. PubMed ID: 29903888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations.
    Li B; Mascarenhas JO; Rampal RK
    Curr Hematol Malig Rep; 2018 Dec; 13(6):588-595. PubMed ID: 30353413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies.
    Brune MM; Rau A; Overkamp M; Flaadt T; Bonzheim I; Schürch CM; Federmann B; Dirnhofer S; Fend F; Tzankov A
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.
    Roug AS; Nyvold CG; Juhl-Christensen C; Christensen M; Schnittger S; Hokland P
    Eur J Haematol; 2011 Nov; 87(5):461-3. PubMed ID: 21689158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration.
    Cappelli LV; Meggendorfer M; Baer C; Nadarajah N; Hutter S; Jeromin S; Dicker F; Kern W; Haferlach T; Haferlach C; Höllein A
    Leukemia; 2022 Feb; 36(2):394-402. PubMed ID: 34376804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
    Shlush LI; Zandi S; Mitchell A; Chen WC; Brandwein JM; Gupta V; Kennedy JA; Schimmer AD; Schuh AC; Yee KW; McLeod JL; Doedens M; Medeiros JJ; Marke R; Kim HJ; Lee K; McPherson JD; Hudson TJ; ; Brown AM; Yousif F; Trinh QM; Stein LD; Minden MD; Wang JC; Dick JE
    Nature; 2014 Feb; 506(7488):328-33. PubMed ID: 24522528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.